m+Medelevator.RU
← Поиск публикаций
Biochemical and biophysical research communications · 2026

Glycochenodeoxycholate promotes IL-8 expression through ER-mitochondrial calcium signaling in human hepatocytes.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Hirai Tomoya, Takemura Akinori, Higuchi Yuichiro, Uehara Shotaro, Yoneda Nao, Suemizu Hiroshi, Ito Kousei

Аннотация

Accumulation of excessive bile acids in the liver contributes to the progression of liver injury; thus, elucidating the bile acid-induced responses remains a critical challenge. Although conjugated bile acids have recently been reported to induce inflammatory responses at non-cytotoxic concentrations, the precise molecular mechanisms involved are not fully understood. The present study investigated the role of intracellular calcium dynamics-focusing particularly on mitochondria-in bile acid-induced inflammatory signaling. Exposure of human hepatocytes isolated from humanized liver chimeric mice (HepaSH cells) to glycochenodeoxycholate (GCDCA), a major component of the human bile acid pool, induced IL-8 mRNA expression at non-cytotoxic concentrations. This induction was significantly suppressed by 2-APB, an inhibitor of inositol 1,4,5-trisphosphate receptors on the endoplasmic reticulum. To clarify the underlying mechanisms, intracellular calcium measurements using fluorescent probes revealed no prominent changes in global cytosolic calcium levels; instead, GCDCA induced a marked increase in mitochondrial calcium levels, which was attenuated by 2-APB co-treatment. Overall, our findings highlight the critical role of mitochondria-centered calcium regulation in bile acid-induced inflammatory responses, providing novel insights into the pathogenesis of cholestatic liver injury.